Mizuho Made the Right Call, Jazz Pharmaceuticals 1.4% Higher (JAZZ)
May 19, 2016 at 01:15 AM EDT
One week ago Jazz Pharmaceuticals (NASDAQ:JAZZ) was upgraded from Neutral to Buy at Mizuho. The stock closed at $150.79, which is 1.4% higher than the price one week ago...
